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Epidemic  typhus  is  an  acute  human  disease  caused  by the  obligate  intracellular 
bacterium,  Rickettsia prowazekii.  R.  prowazekii  has  a  predilection  for  multiplication 
within the endothelial cells lining the capillaries  (1)  and an ability to multiply within 
the  macrophages  of  the  host  (2).  Thus  cells  that  are  not  specially  adapted  for 
phagocytosis as well as professional phagocytes serve as sites of rickettsial  multiplica- 
tion.  Rickettsiae multiply freely in the cytoplasm of their host cells; they do not grow 
within vacuoles. 
The mechanisms of host defense against  the etiological agents of epidemic  typhus 
and other diseases caused by Rickettsia species are not clearly understood, but studies 
have  indicated  the  importance  of both  humoral  and  cell-mediated  immunity.  The 
importance  of specific antibody is suggested by the protective effect of the adminis- 
tration  of immune  serum  in  human  cases  of epidemic  typhus  (3).  In  addition,  R. 
prowazekii  treated  with  specific  antiserum  is  destroyed  within  human  monocyte- 
derived macrophages (4) and mouse macrophage-like cells (5).  Specific antiserum also 
has been reported to inhibit the ability ofR. prowazekii to infect L929 mouse fibroblasts 
(5). 
A  role for cell-mediated  immunity in  host  defense against  rickettsiae  is  indicated 
because spleen cells collected from guinea pigs that had recovered from Rickettsia typhl 
infection could transfer resistance to intradermal  challenge to nonimmune recipients, 
whereas  serum  could  not  (6,  7).  In  addition,  a  T  cell-mediated  mechanism  was 
responsible for the protection of mice immunized with the Gilliam strain of Rickettsia 
tsutsugamushi against subsequent challenge with the Karp strain of R. tsutsugamushi (8). 
T  lymphocytes also function in host defense against Rickettsia akari and Rickettsia conorii 
infections  in  mice  (9,  10).  Other  evidence  for  the  importance  of  cell-mediated 
immunity  derives  from the  fact  that  lymphokines produced  by cultures  of antigen- 
stimulated or concanavalin A-stimulated mouse spleen cells rendered mouse peritoneal 
macrophages capable of killing R. tsutsugamushi (11-13). 
How the host copes with established  rickettsial  infection in nonprofessional  phag- 
ocytes is unknown. We report here that lymphokines inhibit the growth ofR. prowazekii 
in cultured fibroblasts in a species-specific manner and participate  in the destruction 
of rickettsiae within  these nonprofessional phagocytes. 
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Materials  and  Methods 
Cell  Cultures.  Mouse  L929  cells and  human  Flow  5000  cells were  purchased  from  Flow 
Laboratories, Inc., McLean, VA, and mouse 3T3-A31 cells were purchased from the American 
Type Culture Collection, Rockville, MD. Cultures of human foreskin fibroblasts were obtained 
from Mr. Frank Pindak, University of South Alabama. 
L929 cells were grown in Eagle's minimum essential medium supplemented  with  10% calf 
serum; 3T3-A31  cells were grown in Dulbecco's modified Eagle's medium supplemented with 
10%  calf serum;  and  Flow 5000  cells and  human  foreskin  fibroblasts  were  grown  in  Eagle's 
minimum essential  medium supplemented  with  10% fetal calf serum.  Calf and  fetal calf sera 
were heat inactivated at  56°C before use. All cell cultures were grown in tissue culture dishes 
or flasks in a CO2 incubator at 34°C. 
Rickettsiae.  R. prowazekii  was grown in 6-d embryonated,  antibiotic-free hen eggs (Truslow 
Farms, Chestertown, MD) inoculated from seed pools prepared from the E strain or the Breinl 
strain. Rickettsiae were harvested and purified from infected yolk sacs 8 d after inoculation by 
methods  modified  from  those  of Bovarnick  and  Snyder  (14)  and  Wisseman  et  al.  (15),  as 
described  previously  (16).  The  rickettsiae were then  passed  through  a  type AP20 microfilter 
glass filter (Millipore Corp., Bedford, MA) (17,  18) and were stored at -70°C in 0.2-ml aliquots. 
Viable rickettsiae were enumerated by the antibody hemolysis method of Walker and Winkler 
(19). 
Preparation of Lymphokines.  Mouse lymphokines were prepared  by three procedures.  In the 
first procedure, spleen cells obtained from male BALB/c mice (16-32 wk old) were adjusted to 
a  concentration of 5  ×  106 cells/ml in RPMI  1640  medium supplemented  with 5% fetal calf 
serum  and  incubated  with  0.6-1.5  #g/ml  concanavalin  A  (Sigma  Chemical  Co.,  St.  Louis, 
MO).  Alternatively,  spleen  cells  were  obtained  from  mice  immunized  7  d  previously  by 
intraperitoneal  injection  of  1.4  mg  heat-killed  Corynebacterium paroum CN6134  (Burroughs 
Wellcome Co., Research Triangle Park,  NC) and were incubated with  14/zg/ml (dry weight) 
heat-killed C. parvum. In the third procedure, spleen cells were obtained from mice immunized 
7 d  previously by intraperitoneal injection of 105-106  viable rickettsiae (E strain, R. prowazeki 0 
and  were  incubated  with  heat-killed  R.  prowazekii  E  strain  at  a  concentration  of  14  /zg  of 
rickettsial protein/ml. 
All spleen cell suspensions were prepared according to the method of Ruco and Meltzer (20). 
After  incubation  of the  cultures  at  34°C  for  48  h,  the  culture  fluids  were  centrifuged  and 
sterilized by filtration (pore size, 0.2 #m).  The culture fluids (crude mouse lymphokines)  were 
stored at 4°C or -70°C. 
For human  lymphokine production,  tymphocytes and  monocytes were isolated from ethyl- 
enediamine tetraacetate-treated  human  blood samples  by centrifugation of the diluted blood 
over FicolbPaque (Pharmacia  Fine Chemicals, Piscataway,  N  J). The lymphocytes and mono- 
cytes  were  washed  and  resuspended  at  a  concentration  of  1  X  106 cells/ml  in  RPMI  1640 
medium  supplemented  with  5%  fetal  calf serum.  The  cells were  incubated  with  1.5 /zg/ml 
concanavalin A for 72 h at 34°C. Supernatant  fluids (crude human lymphokines) were collected 
and stored at 4°C. 
Treatment of Cells with  Lymphokines and Infection of Cells with  Rickettsiae.  All  cells  were  x- 
irradiated  with a  General  Electric Maximar  100  X-ray unit  at  a  dosage adequate  to prevent 
cell division (3,000-5,000  tad).  After irradiation,  the cell lines L929, 3T3-A31, Flow 5000, and 
human  foreskin  fibroblasts  were adjusted  to a  density of  1.0-1.2  ×  105  viable  (trypan  blue- 
excluding)  cells/ml and  were planted  in eight-chambered  slides  (0.3  ml/ehamber)  (Lab-Tek 
Div., Miles Laboratories  Inc.,  Naperville,  IL).  The cells were  incubated  overnight  in  a  CO2 
incubator  at  34°C.  The  culture  medium  was  then  removed and  the cells were treated  with 
medium  alone  or  with  various  dilutions  of  lymphokines  in  tissue  culture  medium.  After 
incubation for an additional  24 h, the cells were infected with rickettsiae. 
Rickettsiae were diluted  in Hanks'  balanced  salt  solution  supplemented  with 0.1%  gelatin 
and 4.9 mM L-glutamic acid (monopotassium  salt).  Rickettsiae were added to washed cells at 
multiplicities of 100-400 viable rickettsiae per cell. Cells and rickettsiae were incubated together 
for  1 h  at  34°C.  The cells were then washed  twice and  given fresh  tissue culture  medium or 
lymphokines diluted in tissue culture medium. Infected cells were incubated at 34°C for up to 
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were dried with a warm air stream. Slides were fixed in 1% formalin in 0.1 M  sodium phosphate 
buffer, pH 6.8.  The slides were washed in three changes of buffer and were then stained by a 
modification of the Gimenez method, as described by Wisseman et al.  (21). 
Similar experiments were conducted  in  24-well  plates  (Flow  Laboratories,  Inc.)  that  con- 
tained cover glasses.  In these experiments the tissue culture medium  in each well  (1  ml)  was 
cytocentrifuged  onto a  microscope  slide in a  Cytospin  SCA-0031  (Shandon Southern Instru- 
ments Inc., Sewickley, PA). The resultant slides as well as the cover glasses from the wells were 
fixed  and  stained  as  described  above.  A  small  number  of cells  was  present  in  the  smears 
prepared by cytocentrifugation of the tissue culture medium collected from both control and 
lymphokine-treated wells. The approximate number of cells in the medium was estimated by 
counting the  number of cells  in  a  measured  area  of each smear  and comparing it  with  the 
numbers of ceils present in the same areas of smears prepared from known numbers of cells. 
All treatments were done in duplicate at each time point. Slides were examined microscop- 
ically with an oil immersion objective, and the number of rickettsiae present in each of 100 cells 
was counted  for each duplicate of each treatment. When a  cell contained >100  rickettsiae it 
was assigned a  value of 100; this practice causes an underestimate of the number of rickettsiae 
at later times. The percentage of cells infected with rickettsiae  (%R), t  the average number of 
rickettsiae  per infected cell  (RI),  and  the average number of rickettsiae per cell  (NR),  were 
determined. Many of the data were normalized to the zero time infection, e.g.,  RI at a  given 
time divided by RI at zero time multiplied by  100 gives the average number of rickettsiae per 
infected cell as a  percentage of that observed at zero time. 
Experiments with Lymphokines and Inhibitors of Eukaryotic Protein Synthesis,  Irradiated L929 cells 
were  treated  with  tissue  cuhure  medium  alone,  medium  plus  lymphokines,  medium  plus 
lymphokines and inhibitor (cycloheximide,  1 ~g/ml, or emetine, 0.5 p.g/ml), or medium  plus 
inhibitor. Rickettsial growth was monitored as described above. Percent inhibition of rickettsial 
growth in lymphokine-treated chambers (%LK) and percent inhibition of rickettsial growth in 
lymphokine  plus  inhibitor-treated  chambers  (%LKIN)  were  calculated  as  follows  from  the 
values of NR at 48 h  after infection (expressed as percentages of the values of NR observed at 
0  h):  %LK  =  [(NR  control  chambers  -  NR  lymphokine-treated  chambers)/NR  control 
chambers] X  t00. %LKIN =  [(NR inhibitor-treated chambers -  NR lymphokine plus inhibitor- 
treated  chambers)/NR  inhibitor-treated  chambers]  ×  100.  Percent  suppression  of the  anti- 
rickettsial effect of the lymphokines by the inhibitor was calculated from the difference between 
%LK and %LKIN. 
Rapid Method for Assay of Anti-Rickettsial  Activity (ARA ) in Mouse l~ymphokines.  Irradiated L929 
cells  were  treated  before  and  after  rickettsial  infection  with  dilutions  of  the  lymphokine 
preparation to be assayed and were examined 48 h  after infection with rickettsiae. A  cell was 
scored positive for rickettsial growth  if it contained  10 or  more rickettsiae, and negative if it 
contained  9  or  fewer  rickettsiae.  At  48  h  after  infection,  60-90%  of the cells  in  the  control 
chambers were positive for rickettsial growth whereas at 0 h, <5% of the cells had been positive 
by  this criterion.  Percent  inhibition of rickettsial growth  was  calculated  from  the  difference 
between  the  percentages  of positive  cells  in  control  and  treated  chambers.  The  amount  of 
lymphokine that would cause 50% inhibition of rickettsial growth in a  slide chamber (0.3 ml) 
was defined as  1 U  of ARA. 
Results 
Effect of Mouse Lymphokine  Treatment of L929 Cells on their b~teraction with R. prowazekii 
(E Strain).  The  time at which lymphokines  were presented was an important  factor 
in determining  the degree of rickettsial clearance  and  inhibition of rickettsial growth 
in  lymphokine-treated  L929  cells.  Fig.  1  shows  the  results  of several  experiments  in 
which %R and RI were monitored  at 0, 24, and 48 h  after rickettsial infection in L929 
cells  treated  with  lymphokines  before  infection,  after  infection,  or  before  and  after 
Abbreviations used in  this paper: ARA,  anti-rickettsial activity; %LK,  percent  inhibition of rickettsial 
growth in lymphokine-treated chambers; ~7~I,KIN, percent inhibition of rickettsial growth in lymphokine 
plus  inhibitor-treated chambers;  NR,  average  number of rickettsiae  per  cell;  RI,  average  number of 
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HOURS  AFTER  INFECTION 
Fie.  l.  Effect of mouse lymphokine treatment of mouse L929 cells on the growth of R. prowazekii 
E strain in these cells. Lymphokines were induced with the immunogen C. parvum or R. prowazekii or 
with concanava[in A. L929 cells were treated with 10-20% mouse spleen cell supernatant  (lympho- 
kines) (squares);  control cultures received tissue culture medium alone (O). The percentage of cells 
infected and the average number of rickettsiae per infected cell are expressed as percentages  of the 
values observed at zero time. IN, cells treated with lymphokines  24 h before infection; vA, cells treated 
with lymphokines 24 h before infection and after infection; l, cells treated with lymphokines  after 
infection.  Each  value represents  the mean  _  the standard  error of the mean  for three or more 
experiments. The percentage of cells infected at 0 h was 71 _+ 3 for control cells and 69 +  3 for cells 
treated with lymphokines 24 h before infection.  The average number of rickettsiae  per infected  cell 
at 0 h was 2.6 +  0. l for control ceils and 2.4 +  0.1  for cells treated with lymphokines  24 h before 
infection. 
infection.  Decreases in  %R relative to the values observed  at  zero time indicate total 
clearance of rickettsiae from some of the cells. Treatment  of L929 cells with iympho- 
kines for 24 h  before rickettsial  infection resulted  in complete clearance of rickettsiae 
from  more  than  one-half of the  infected  cells by  24  h  after  infection.  %R  remained 
about  the  same  during  the  next  24  h  in  cells treated  with  lymphokines  only  before 
infection, but  this parameter  continued  to decrease in cells treated with lymphokines 
both before and after infection. When  lymphokines were present  only after rickettsial 
infection, there was a  slower and  less pronounced  decrease in %R. 
During the 48 h  period after infection, RI, an index of rickettsial growth, increased 
19-fold in control cultures  (Fig.  1).  However, in cells treated with lymphokines both 
before  and  after  infection,  RI  underwent  little change.  Thus  rickettsial  growth  was 
almost  completely  inhibited  in  the  lymphokine-treated  cells that  remained  infected. 
Partial  inhibition  of rickettsial  growth  was  observed  when  L929  cells  were  treated 
with  lymphokines  either only  before or only after infection.  In  ceils pretreated  with 
lymphokines  for 24 h  before infection rickettsial  growth  was most suppressed  during 
the first  24 h  after infection.  In contrast,  in cells treated  with  lymphokines  only after 
infection  the most  marked  inhibition  was  apparent  during  the period  from  24  to  48 
hr after infection. 
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the presence of small numbers  of suspended  L929 cells in both  control  and  lympho- 
kine-treated culture  fluids.  The  cells present  in the culture  fluids represented  6-14% 
of the total cells in the cultures.  Rickettsial  growth  was evident  in  many  of the cells 
present in the smears prepared  from control cultures but not in the cells present in the 
smears prepared  from lymphokine-treated  cultures. 
The  effect of pretreatment  of L929 cells with lymphokines  for 24 h  on the ability of 
the cells to  be  initially infected with  rickettsiae was  variable.  In  46 experiments  the 
average  %R  at  0  h  were  83  +  2%  and  71  +  3%  in  control  and  lymphokine-treated 
cells, respectively.  RI  at 0  h  were  3.7  +  0.2  for the control cells and  2.9 +_ 0.2 for the 
lymphokine-treated  cells. Although  these mean  values did not reveal dramatic  differ- 
ences between  the control  and  lymphokine-treated  groups,  the data  from  individual 
experiments  showed that  the RI  in lymphokine-treated  cultures was <75%  of that  in 
control cultures in 24 of the 46 experiments. 
Inhibition  of  the  Growth  of R.  prowazekii  (Avirulent  and  Virulent  Strains)  by  Various 
Concentrations  of Mouse Lymphokines.  Table  I  demonstrates  the effect of three concen- 
trations of mouse lymphokines on the growth of the avirulent E  strain and the virulent 
Breinl slrain of R. prowazekii in L929 cells. The  L929 cells were treated with dilutions 
of lymphokines  both  before  and  after  infection  with  rickettsiae,  and  the  infection 
parameters,  %R and  RI, at 24 and 48 h  after infection were expressed  as percentages 
of the  values  observed  at  zero  time.  The  controls  indicate  that  the  two  rickettsial 
strains grew comparably  in untreated  L929 cells; %R underwent  little change  and  RI 
increased -18-fold  during  the 48 h  period after infection. At the highest lymphokine 
concentration,  %R  and  RI  decreased  for both  strains of R. prowazekii during  the 48 h 
TABLE  I 
Inhibition of the Growth of R. prowazekii  (Avirulent and Virulent Strains) and R. conorii in L929 Cells" 
Treated with Mouse Lyraphokines* 
R. prowazekii 
Dilution  Hours  R. prowazekii (E strain)  (Breinl strain) 
of lym-  after 
phokines  infection  %R  RI  %R  RI 
R. conorii 
%R  RI 
Control  0  (85 ±  7)  (4.7  ±  2.0)  (84 ±  11)  (4.0 ±  1.5)  (39 ±  4)  (1.7 ±  0.0) 
24  97 ±  2  387 ±  45  94 ±  2  410 ±  26  161 ±  16  2147 ±  147 
48  103 ±  3  1734 ±  533  108 ±  10  1873 ±  591 
1/20  0  (83 ±  7)  (4.0 ±  2.0)  (84 ±  9)  (3.5 ±  1.0) 
24  80 ±  13  311 ±  122  65 ±  8  136 ±  16 
48  77 ±  8  903 ±  306  54 ±  6  559 ±  247 
1/10  0  (81 +  9)  (4~2 +  2.0)  (89 +  5)  (3.4 ±  0.7) 
24  83 +  13  129 +  8  54 +  8  78 -3- 25 
48  7l +  6  224 +  101  38 "+ 9  102 -J- 32 
1/5  0  (85 +  8)  (4.8 ±  2.0)  (86 +  7)  (3.9 "4- 1.0)  (39 -4- 3)  (1.5 ±  0.1) 
24  77+  13  86±8  53+  1  61 ___3  77+2  325±  163 
48  51 +21  80+6  39+8  67~6 
* L929 cells were treated with tissue culture medium alone or with dilutions of concanavalin A-induced 
mouse lymphokines for 24 h  before infection and after infection with rickettsiae. The actual values of 
%R  and  R[  at  0  h  are  in  parentheses. %R  and  RI  at  24  and  48  h  after infection are  expressed  as 
percentages of those values observed at 0 b, Each value represents the mean ±  standard error for two or 
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period after infection; hence, inhibition of growth and even clearance of a substantial 
proportion  of the  rickettsiae  from  the  infected  fibroblasts  occurred.  At  the  lower 
lymphokine concentrations,  the changes  in  %R  and  RI  with either strain  were less 
dramatic  than  those  observed  at  the  highest  lymphokine  concentration.  The  data 
indicate  that  lymphokine treatment  of L929  cells  had  similar dose-dependent  anti- 
rickettsial effects on both the avirulent  E  and virulent  Breinl strains of R. prowazekii 
within the L929 cells. 
R. prowazekii was not unique among Rickettsia species in its sensitivity to the effects 
of lymphokines:  lymphokine treatment  of L929  cells  also suppressed  the  growth  of 
Rickettsia conorii, a  member of the spotted fever rickettsial group (Table I). 
Effect of Inhibitors  of Eukaryotic Protein Synthesis  on the Inhibition  of Rickettsial Growth  in 
L929 Cells by Mouse Lymphokines.  Addition ofcycloheximide  (1  #g/ml)  to L929 cells 
at the same time as lymphokines markedly suppressed the inhibition of the growth of 
R. prowazekii by mouse lymphokines. This suppressive effect of cycloheximide on the 
anti-rickettsial effect of the lymphokines was observed when lymphokines and cyclo- 
heximide were incubated with L929 cells only before rickettsial infection, only after 
infection,  or both  before  and  after  infection  (Table  II).  Addition  of cycloheximide 
alone  to  L929  cells  was  sometimes  associated  with  slight  inhibition  of rickettsial 
growth in the cells. 
Percent suppression of the anti-rickettsial effect of mouse lymphokines by cyclohex- 
TABLE  II 
Effect of Cycloheximide or Emetine on the Inhibition of Rickettsial Growth in L929 cells by Mouse 
Lymphokines 
Time of treatment of L929 cells with lymphokines and/or inhibitor¢ 
Houl~s 
24 h  before infection and 
Treatment of L929 ceils*  aftel  24 h  before infection  After infection 
ariel infection 
infection 
'7, R  RI  9~R  RI  '~R  RI 
Ctmtro]  0  (90 ±  8)  (5.4 4-  1.8)  (77 4- 9)  (3.8 4-  1.2)  (79 4- 4)  (3.4 4- 0.5) 
48  97±3  1097+153  98±2  15084-257  105+6  17724-271 
I,ymphokines  0  (65 4- 25)  (2.7 ±  1.2)  (67:1:  I I)  (2.5 ±  0.5)  (79 ±  4)  (3.4 4- 0.5) 
48  64 4-  I  175 ±  81  38 ±  II  103 ±  14  83 ±  7  325 ±  68 
l,ymphokines  plus  I  ,ug/ml  0  (88 4- 6)  (3.5 4-  1.0)  (68 :t:  I2)  (2.6 ±  0.7)  (79 ±  4)  (3.4 ±  0.5) 
cycloheximidc  48  89 ±  1  958 ±  2  79 4- 5  1060 4- 567  98 +  4  1221  4- 304 
1 btg/m] cycloheximide  0  (90 ±  3)  (3.7 4- 0.6)  (73 4-  10)  (2.8 4- 0.6)  (79 ±  4)  (3.4 ±  0.5) 
48  934-3  1235±137  814-8  1261±278  105±5  15764-326 
Control  0  (87 ±  4)  (4.2 4- 0.7) 
48  103 ±  6  1581  4- 410 
Lymphokincs  48  86 +  I  ]78 ±  21 
t,ymphokh~es plus 0.5/sg/m]  4B  102 4-  1  933 ±  336 
enwtine 
0.5 tLg/ml  emetine  48  99 ±  4  1166 ±  425 
* Lymphokincs were the supernatant fluids collected from motuse spleen cells cultured in the presence of concanavalin A or antigen (G~ pawum 
o1' R. prou,azekit) for 48 h  Lymphoklnes were used at a concentration  of 10- 20f~. 
.~ %R and R1 at O h are shown in parentheses. ¢~,R and RI at 48 h after rickettsial  infection arc expressed as percentages of the values observed 
at 0 h. Each value represents  the mean +  the standard error of the mean. Treatment with lymphokinc's  and/or cycloheximide before infection, 
n  =  2  experiments;  treatment  before and after infection, n  ~  4 experiments;  treatment after infection, n  =  I I  experiments;  treatment with 
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imide  varied  in  different  experiments.  For  example,  in  L929  cells  treated  with 
lymphokines and/or cycloheximide only after rickettsial infection, percent suppression 
of the  anti-rickettsial  effect  by  cycloheximide was  >96%  in  3  of  11  experiments, 
between 45 and 75% in  7 experiments, and 20% in the remaining experiment. When 
lymphokines and/or cycloheximide were added  to L929 cells  both  before and  after 
infection,  percent  suppression  of the  anti-rickettsial  effect  of the  lymphokines  by 
cycloheximide was >90% in two of four experiments and was  18% in  the remaining 
two  experiments.  Some  of this  variability  may  be  due  to  the  toxicity  of certain 
lymphokine-cycloheximide combinations  for  L929 ceils,  especially  when  ceils  were 
treated  both  before  and  after  infection.  Enmtine,  another  inhibitor  of eukaryotic 
protein synthesis, also suppressed the inhibition of rickettsial growth in L929 cells by 
mouse lymphokines (Table II). 
Species  Specificity  of the  ARA  in  Mouse  and  Human  Lymphokines.  Clearance  of R. 
prowazekii and inhibition of rickettsial  growth occurred in mouse lymphokine-treated 
3T3-A31 mouse fibroblasts as well as in mouse lymphokine-treated mouse L929 cells 
(Table  III). However,  rickettsial  survival  and  growth were  not  inhibited  in  mouse 
lymphokine-treated human foreskin fibroblasts  (Table IIl) or in mouse lymphokine- 
treated  human  Flow  5000  cells  (data  not  shown).  Similarly,  human  lymphokine 
treatment of human foreskin fibroblasts resulted in rickettsial clearance and inhibition 
of rickettsial  growth in these cells, but human lymphokine treatment of mouse L929 
cells  had no effect on rickettsial survival and growth (Table III). 
Assay of ARA  in Mouse Lymphokines.  As demonstrated in Table I, it was possible to 
measure  the  anti-rickettsial  potency of a  given  mouse  lymphokine preparation  by 
determining  the  effects  of dilutions  of the  preparation  on  rickettsial  survival  and 
growth as measured by %R and RI. This method was very time-consuming; hence we 
developed a  more rapid and convenient scoring method for determining the titer of 
ARA in  lymphokine preparations  when  the  details  of the  parameters  of rickettsial 
growth were not of special interest  (details in Materials  and Methods).  Fig. 2 shows 
TABI.e III 
Effect of Mouse and Human Lymphokines on the Growth of R. prowazekii 
in Mouse and Human Cell Lines* 
Cell  lmc 
Treatment  bt:ff)le  ~LIOUlS  after 
Mouse  L929  Mouse  3"F3-A31  Human  foreskin  fibroblasts 
and aftcl infection  infection 
'/~ R  R1  ')', R  R1  ':;R  R1 
Control 
Mouse I~ mphokines 
Human  lymphokines 
o  (90+-I)  (4.6 +-_ 0.5)  (47±111  (27±0H  (55 ±  B)  (2.7  m  041 
24  94 ±  3  531  ±  49  1(14 q-  211  ;161 ±  74  112 ±  9  6113 ±  107 
48  9,3 ±  5  1632 ±  131  94 ±  2(1  I,ll:3 ±  2((1  143 ±  12  2.285  +  ,15q 
1)  (77 +-- ;)  {~.5  ~  ()41  (211 ±  7)  (2{1  +-- ()kl  (~5 ±  I0)  (251  ___ (1:51 
24  )5{J ±  8  131  ±  20  39 +-- 8  !)5 -+ 0  176 ±  48  562 ±  72 
48  ',7+-6  2(17±32  54±1,t  ~H±13  215±34  2,101±'225 
0  (87 ±  6)  (45+_  11)  NI)$  ND  (3~1 ±  8)  (21  --_01) 
24  !17 +  I  425  ±  64  NI)  NI)  5(I ±  g  138 ±  30 
48  93 ±  2  1430 ±  359  NI)  NI)  (i5  -+ 22  "~74 ±  144 
* Cells  were  tt~'atcd  with  tissue  cu[turc  medinnl  ~t~()11(~ ot  with  20~,  mouse  or  human  lytxlph0klnes  in  tisstlc  culttne  /nedi,nl.  Xfahtcs  in 
pal-cntheses  tt'pv('sent  ~ 1~. and R1 at  0  h. %R  and  R[ at  24 and 48 h  after  hlR-ction ate cxpicsscd  as petccF~t~tK¢'~ ~[ [ht- valttcx ob~ct vcd 2~t o 
h, Eat:J1  value I~'prescnts the ll]C~ll  ~+ standard  c~to~  lot  two or move experiments. 
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FIG.  2.  Dose-response curve for the inhibition of rickettsial  growth by mouse lymphokines. L929 
cells were treated with dilutions of lymphokines both 24 h before infection and after infection with 
R. prowazekii E strain. Infected cultures were incubated for 48 h, stained, and examined microscop- 
ically.  The data shown were collected in  18 experiments. The number of units of ARA per 0.3  ml 
of a  given lymphokine preparation was the reciprocal of that dilution which by interpolation gave 
50%  inhibition. The units of ARA present and percent inhibition  for all  of the dilutions of each 
experiment were plotted. For example, if a  1:40 dilution caused 60% inhibition and a  1:80 dilution 
caused 30%  inhibition, by interpolation a  1:50 dilution would cause 50% inhibition  (I  U/0.3 ml). 
Hence there would be 50 U/0.3 ml in the undiluted lymphokine and  1.25 U caused 60% inhibition, 
whereas 0.63  U  caused  30%  inhibition.  This assay provided a  relatively  rapid  and  standardized 
evaluation of the potency of particular lymphokine preparations. 
a  dose-response curve obtained  by plotting percent  inhibition  of rickettsial  growth 
against calculated units of ARA. Data shown were pooled from  18 experiments. 
During these studies we assayed the ARA in  24 preparations  of concanavalin A- 
induced mouse lymphokines. Four of these preparations contained < 10 U  of ARA in 
0.3  ml and were therefore not  used  in experiments.  The remaining 20 preparations 
contained  between  18  and  238 U  of ARA in  0.3  mi  (mean  =  68  U).  Two control 
culture supernatants  obtained  from  mouse spleen  cells  incubated  for 48 h  without 
concanavalin A  and  one control supernatant  prepared  from spleen  cells  incubated 
with concanavalin A for 1 h all contained <3 U  of ARA in 0.3 ml. 
Four C. parvum-induced  mouse lymphokine preparations contained ARA ranging 
from  21  to  76  U/0.3  ml  (mean,  40  U);  and  two R, prowazekii-induced  lymphokine 
preparations  contained  38  and  103  U  in  0.3  ml.  One  supernatant  obtained  after 
incubation of spleen cells  of C. parvum-immunized mice for 48 h  without additional 
immunogen contained  16 U  of ARA in 0.3  ml, and one preparation obtained after 
incubation of spleen cells ofR. prowazekii-immunized mice for 48 h without additional 
immunogen contained <3 U  in 0.3 ml. 
In Table I, the concentration of ARA at the highest dilution of mouse lymphokines 
(1:20)  was ~1  U/0.3 ml. In Fig.  1 and Tables II and III, mouse lymphokine-treated 
cells were treated with at least 3 U of ARA/0.3 ml. 
Prelimina~7 Characterization of the ARA  in Mouse Lymphokines.  Table  IV shows  the 
results of several experiments in which the ARA in crude mouse lymphokines induced 
with  concanavalin A  was  assayed  after  the  lymphokines were  subjected  to  various 
treatments. Substantial amounts of the ARA remained after heating the lymphokines 
at 56°C for 30 rain. However, heating the lymphokines at 80°C for 10 min destroyed 982  INHIBITION  OF RICKETTSIAL  GROWTtt BY  LYMPHOKINES 
TABLE IV 
Effect of Various Treatments on ARA in Mouse Lymphokines* 
Lymphokine treatment  Experiment  ARA (U/0.3 ml):~ 
Untreated  1  28  (100)§ 
2  35 
3  61 
56°C, 30 min  1  24  (86) 
2  23  (66) 
3  38  (62) 
80°C, 10 min  l  <2.5  (<9) 
2  <2.5  (<8) 
3  <2.5  (<4) 
Untreated  4  31  (100) 
5  46 
Dialyzed  4  17  (55) 
5  18  (39) 
pH 2, 24 h; dialyzedll  4  <4  (<13) 
5  <2.5  (<6) 
* Mouse lymphokines  were the supernatant fluids collected from mouse spleen 
cells cultured in the presence of concanavalin A for 48 h. 
~t ARA was assayed as defined in Materials and Methods. 
§ Numbers in parentheses express the titer of the treated lymphokine sample 
as  a  percentage of the  titer  of the corresponding untreated  lymphokine 
preparation. 
II Samples of lymphokines were adjusted to pit 2 with  l  N ttCI  and were 
allowed to stand at 4°C for 24 h. Lymphokines were then dialyzed against 
Eagle's minimum essential medium and sterilized by filtration. 
the ARA. Treatment of the lymphokines at pH 2 for 24 h  followed by dialysis of the 
lymphokines also resulted in destruction of the ARA. 
Discussion 
Roles  for  both  specific antibody and sensitized T  lymphocytes in anti-rickettsial 
immunity have been indicated (3, 4, 6-13), but the mechanisms of protection have 
not  been  well  defined.  Destruction  of  antibody-treated  rickettsiae  occurs  within 
macrophages (4), and destruction of rickettsiae by lymphokine-activated  macrophages 
has also been noted  (11-13).  However, destruction of R.  prowazekii by macrophages 
would  seem  to  be  insufficient  for  eliminating rickettsiae  in  the  host  because  the 
endothelial cells (nonprofessional phagocytes) lining the capillaries are major sites of 
rickettsial multiplication (1).  Destruction of infected cells by sensitized T  cells and/or 
establishment of conditions unsuitable for  rickettsial  survival and  growth  in  non- 
professional  phagocytes  would  constitute  important  mechanisms  of  host  defense 
against R. prowazekii and other Rickettsia species. The former mechanism would require 
alteration of the membranes of the infected host cells and a cytotoxic mechanism that 
would not only lyse the altered host cells but also destroy the rickettsiae within these 
cells.  No  evidence  exists  to  support  such  a  mechanism  of  defense  in  rickettsial 
infections. The latter mechanism would involve less damage to  host  tissues, and in JENIFER  TURCO AND HERBERT  H.  WINKLER  983 
vitro correlates of this possible host defense mechanism are provided by the present 
study.  The  lymphokines  used  in  this  study  induced  anti-rickettsial  conditions  in 
fibroblasts. Thus mediators produced by sensitized cells may function in controlling 
rickettsial survival and growth in nonprofessional phagocytes in the infected host. 
Several  features of the  lymphokine-rickettsia-host cell  interaction  deserve further 
emphasis.  First,  the  lymphokines themselves, which  were  produced  by spleen  cells 
after stimulation  with mitogen or antigen,  were probably not  directly toxic for the 
rickettsiae:  not  only  were  the  lymphokines species  specific,  but  the  anti-rickettsial 
effect  was  suppressed  when  lymphokines  were  added  to  fibroblasts  along with  an 
inhibitor of eukaryotic protein synthesis. Second, the development of anti-rickettsial 
conditions  within  mouse  fibroblasts  did  not  occur  immediately  after  lymphokine 
addition  because  rickettsial  growth  during  the  first  24  h  after infection  was  more 
strongly inhibited in cells pretreated with lymphokines for 24 h  than in cells treated 
with  lymphokines  only  after  infection.  The  presence  of the  lymphokines  may  be 
required for continued expression of ARA because the inhibition of rickettsial growth 
in  L929 cells treated  with  lymphokines both before and  after infection was greater 
than the inhibition observed in cells treated with lymphokines only before infection. 
Finally, the avirulent E  strain of R. prowazekii was not more susceptible to the anti- 
rickettsial  conditions  induced  by lymphokines  in  fibroblasts than  was  the  virulent 
Breinl strain. 
Induction  of microbistatic or microbicidal  activity in  macrophages or monocytes 
by lymphokines has been noted by many researchers  (12,  22-30).  In contrast,  there 
have  been  very  few  reports  of the  induction  of such  activity  in  nonprofessional 
phagocytes by lymphokines.  One  report  described  the  inhibition  of the  growth  of 
Toxoplasma and Besnoitia in  hamster fibroblasts and  kidney cells treated with super- 
natants derived from cultures of antigen-stimulated hamster lymphocytes (31).  Inhi- 
bition  of the  growth  of Toxoplasma in  mouse  L929  cells  treated  with  supernatants 
obtained from cultures of antigen-stimulated mouse spleen cells has also been noted 
(32).  The anti-Toxoplasma factor in this system had certain properties in common with 
interferon-y (32). 
Because  the  induction  of ARA  in  mouse  fibroblasts  by mouse  lymphokines was 
inhibited by cycloheximide or emetine, and because mouse and human lymphokines 
induced  ARA in  fibroblasts of the homologous species but  not  in  fibroblasts of the 
heterologous species, the anti-rickettsial factor (or one of the anti-rickettsial factors) in 
our lymphokine preparations might be an interferon.  Inhibition of the growth of R. 
akari in mouse fibroblasts by virus-induced, pH 2-stable interferon was described over 
10 years ago (33).  However, it seems highly unlikely that mouse interferons fl and a 
are  responsible  for  the  ARA  of our  concanavalin  A-induced  mouse  lymphokine 
preparations because these interferons are stable at pH 2 (34, 35), whereas the ARA 
in our concanavalin A-induced mouse lymphokines was destroyed by exposure to pH 
2. The relative stability of the ARA at 56°C also contrasts with the instability of such 
interferons at 56°C  (34). 
Interferon-y, however,  remains a  possible candidate  for all or some of the  ARA 
because it is labile at pH 2 and stable at 56°C  (34).  Interferon-y is produced in spleen 
cell cultures  after stimulation  with  antigens  or mitogens  (reviewed in  36),  and our 
concanavalin  A-induced  mouse  lymphokine preparations  contain  antiviral  activity 
that  is labile at pH 2  (data not shown).  Experiments are currently being conducted 984  INHIBITION OF  RICKETTSIAL GROWTtt  BY  LYMPHOKINES 
in our laboratory to determine the nature of the lymphokines responsible for inhibiting 
the survival and growth of R. prowazekii  in fibroblasts. 
Summary 
The effect of lymphokine treatment  of mouse  and  human  fibroblast cell lines on 
the  growth  of Rickettsia  prowazekii  within  the  fibroblasts was  studied.  Treatment  of 
mouse L929 cells with concanavalin A- or antigen-induced mouse lymphokines both 
before and after infection with R. prowazekii  led to clearance of the rickettsiae from a 
substantial proportion of the cells and suppression of rickettsial growth in those cells 
which  remained  infected.  Similar but  less dramatic  anti-rickettsial effects were  oh- 
served  in  L929  cells  treated  with  mouse  iymphokines  either  only  before  or  after 
infection with rickettsiae. Mouse lymphokine treatment of L929 cells had similar anti- 
rickettsial  effects  on  the  avirulent  E  strain  and  the  virulent  Breinl  strain  of  R. 
prowazekii.  Addition of cycloheximide or emetine to L929 cells at the same time as the 
lymphokines markedly suppressed the inhibition of rickettsial growth by the lympho- 
kines. Mouse lymphokine treatment inhibited rickettsial survival and growth in mouse 
3T3-A31  cells as well as in mouse L929 cells, but had no effect on rickettsial survival 
and  growth  in  human  foreskin  fibroblasts.  Conversely,  concanavalin  A-induced 
human  lymphokines  inhibited  rickettsial  survival  and  growth  in  human  foreskin 
fibroblasts but  had no effect on  rickettsial survival and growth  in mouse L929 cells. 
The rickettsia inhibitory activity in concanavalin A-induced mouse lymphokines was 
destroyed  by  heating  the  lymphokines  at  80°C  for  10  rain  or  by  holding  the 
lymphokines at pH 2 for 24 h  but was retained after heating at 56°C  for 30 min. 
The  authors  thank  Robin  M.  Daugherty  for  technical  assistance with  the  preparation  of 
lymphokines. 
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